{
      "Rank": 342,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [],
      "ArmGroupInterventionName": [
            "Procedure: Oral mucosa biopsy",
            "Procedure: Sinus lift with implantation of tissue engineered construction",
            "Device: Dental implant"
      ],
      "ArmGroupLabel": [
            "Tissue engineered construction implantation"
      ],
      "ArmGroupType": [
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT02209311"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Autologous MMSCs will be isolated from oral mucosa biopsy sample and expanded in vitro.Tissue engineered construction will be created using synthetic tricalcium phosphate and autologous MMSCs. Patients will undergo sinus lift procedure with implantation of created tissue-engineered construction. This is a single arm study with no control. All patients receive cell therapy."
      ],
      "BriefTitle": [
            "Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "March 2018"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Partially Edentulous Maxilla",
            "Alveolar Bone Atrophy",
            "Alveolar Bone Loss"
      ],
      "ConditionAncestorId": [
            "D000020763",
            "D000009059",
            "D000009057",
            "D000001862",
            "D000001847",
            "D000009140",
            "D000055093",
            "D000010510"
      ],
      "ConditionAncestorTerm": [
            "Pathological Conditions, Anatomical",
            "Mouth Diseases",
            "Stomatognathic Diseases",
            "Bone Resorption",
            "Bone Diseases",
            "Musculoskeletal Diseases",
            "Periodontal Atrophy",
            "Periodontal Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC07",
            "All",
            "BC23",
            "BC05"
      ],
      "ConditionBrowseBranchName": [
            "Mouth and Tooth Diseases",
            "All Conditions",
            "Symptoms and General Pathology",
            "Musculoskeletal Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Atrophy",
            "Alveolar Bone Loss"
      ],
      "ConditionBrowseLeafId": [
            "M11178",
            "M3741",
            "M17899",
            "M21672",
            "M11171",
            "M11169",
            "M4293",
            "M4278",
            "M11249",
            "M27178",
            "M12571"
      ],
      "ConditionBrowseLeafName": [
            "Mouth, Edentulous",
            "Atrophy",
            "Alveolar Bone Loss",
            "Pathological Conditions, Anatomical",
            "Mouth Diseases",
            "Stomatognathic Diseases",
            "Bone Resorption",
            "Bone Diseases",
            "Musculoskeletal Diseases",
            "Periodontal Atrophy",
            "Periodontal Diseases"
      ],
      "ConditionBrowseLeafRelevance": [
            "low",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000016301",
            "D000001284"
      ],
      "ConditionMeshTerm": [
            "Alveolar Bone Loss",
            "Atrophy"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "N/A"
      ],
      "DesignInterventionModel": [
            "Single Group Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "Patients with verified diagnosis partially edentulous maxilla and alveolar bone atrophy will undergo oral mucosa biopsy and autologous MMSCs will be derived and expanded in vitro during 3-4 weeks. After that tissue engineered construction will be created using synthetic tricalcium phosphate and autologous MMSCs. Patients will undergo sinus lift procedure with implantation of created tissue-engineered construction. Six months later patients will undergo dental implant installation. Biopsy of bone tissue at the site of sinus lift will be performed as a part of dental implant installation with subsequent histological analysis of bone specimen."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nPartially edentulous maxilla\nHeight of the bone tissue in the area of reconstruction 1 - 5 mm according to results of cone-beam computed tomography\nMinimal height of the augmentation - 8 mm\nVolume of bone tissue deficiency of the alveolar process of the maxilla 3 - 5 cm3\nImplant installation scheduled to be at least 6 months after sinus-lift operation\nPatient is familiar with Participant information sheet\nPatient signed informed consent form\n\nNon-inclusion Criteria:\n\nChronic and acute ear, nose and throat diseases, including maxillary sinusitis, foreign bodies in the maxillary sinus, odontogenic and not odontogenic maxillary sinus cyst\nMedical history of surgery on maxillary sinuses during preceding 6 months prior to implantation of tissue engineered construction\nProgressive somatic disease (clinically significant diseases of the cardiovascular, hematopoietic or endocrine system, systemic diseases, immunopathological states)\nPatients with malignant tumors including postoperative period, patients receiving chemotherapy and/or radiotherapy\nAny conditions limiting compliance (dementia, neuropsychiatric disease, drug and alcohol abuse etc.)\nSignificant weight loss (> 10% of body weight in the previous year) of unknown etiology\nPatient prescribed for any medications with proven effect on bone metabolism\nDiabetes mellitus, disorders of thyroid and parathyroid glands\nClinically significant abnormalities in results of laboratory tests\nParticipation in other clinical trials (or administration of investigational drugs) during 3 months prior inclusion\n\nExclusion Criteria:\n\nPatient's refusal from the further participation in trial\nPatient's refusal from compliance with the requirements of contraception during the participation in research\nPlaque index (PI)> 15%\nSulcus bleeding index (SBI) > 10%\nChronic kidney disease IV - V stages (creatinine clearance < 30 mL/min estimated by Cockroft-Gault formula)\nConfirmed syphilis, HIV, hepatitis B or C infections\n\nDropout Criteria:\n\nPerforation of the Schneider's membrane more than 5 mm on the stage of the sinus-lift operation\nPregnancy"
      ],
      "EnrollmentCount": [
            "12"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Tissue engineered construction implantation",
            "Tissue engineered construction implantation",
            "Tissue engineered construction implantation"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Oral mucosa biopsy",
            "Sinus lift with implantation of tissue engineered construction",
            "Dental implant"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Procedure",
            "Procedure",
            "Device"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Alveolar Bone Loss",
            "Alveolar Bone Atrophy",
            "Dental Implantation",
            "Bone Tissue Reconstruction",
            "Sinus Lift",
            "Autologous Multipotent Mesenchymal Stem Cell",
            "Autologous MMSCs",
            "Synthetic Tricalcium Phosphate",
            "Tissue Engineered Construction",
            "Oral Mucosa"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Enrolling by invitation"
      ],
      "LastUpdatePostDate": [
            "November 30, 2016"
      ],
      "LastUpdatePostDateType": [
            "Estimate"
      ],
      "LastUpdateSubmitDate": [
            "November 29, 2016"
      ],
      "LeadSponsorClass": [
            "OTHER_GOV"
      ],
      "LeadSponsorName": [
            "Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Moscow",
            "Moscow"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "Russian Federation",
            "Russian Federation"
      ],
      "LocationFacility": [
            "Federal State Budgetary Institution \"Central Clinical Hospital with Outpatient Health Center\" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies",
            "A.I. Evdokimov Moscow State Medical Stomatological University"
      ],
      "LocationState": [],
      "LocationStatus": [],
      "LocationZip": [
            "121359",
            "127473"
      ],
      "MaximumAge": [
            "60 Years"
      ],
      "MinimumAge": [
            "20 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Tissue Engineered Construction Based on a Synthetic Tricalcium Phosphate and Autologous Multipotent Mesenchymal Stromal Cells Obtained From Oral Mucosa"
      ],
      "OrgClass": [
            "OTHER_GOV"
      ],
      "OrgFullName": [
            "Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation"
      ],
      "OrgStudyId": [
            "RU-CCH-06-01-14"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "A.I. Evdokimov Moscow State Medical Stomatological University",
            "Federal State Budgetary Institution \"Central Clinical Hospital with Outpatient Health Center\" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies"
      ],
      "OverallOfficialName": [
            "Grigory Volozhin A Volozhin, MD, PhD",
            "Ilya I Eremin, MD, PhD"
      ],
      "OverallOfficialRole": [
            "Principal Investigator",
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 1",
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "October 2017"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [],
      "PrimaryOutcomeMeasure": [
            "Number of serious adverse events (SAEs) and serious adverse reactions (SARs)"
      ],
      "PrimaryOutcomeTimeFrame": [
            "1 week after treatment"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Quality of life estimated by validated questionnaire: the Short Form (36) Health Survey (SF-36).",
            "Changes in volume and density of bone tissue at the site of manipulation and newly formed bone micro-architecture assessed by cone beam CT (morphometrical analysis using Hounsfield unit measurements)",
            "Biopsy of bone tissue at the site of sinus lift will be performed as a part of dental implant installation. Bone sample will be evaluated histologically: absolute value of the newly formed bone will be calculated using histomorphometrical analysis."
      ],
      "SecondaryOutcomeMeasure": [
            "Quality of life monitoring",
            "Changes in bone tissue volume",
            "Correlation of morphometrical analysis using cone beam CT scan with absolute value of the newly formed bone"
      ],
      "SecondaryOutcomeTimeFrame": [
            "up to 24 weeks after treatment",
            "up to 24 weeks after treatment",
            "24 weeks after treatment"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "September 2014"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "November 2016"
      ],
      "StdAge": [
            "Adult"
      ],
      "StudyFirstPostDate": [
            "August 5, 2014"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "August 4, 2014"
      ],
      "StudyFirstSubmitQCDate": [
            "August 4, 2014"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}